22174 The Modern Management of Myelofibrosis: Practical Perspectives Surrounding the Use of JAK Inhibitors and Novel Therapeutics in the Peri-Transplant Setting
The past decade has seen new insights into the cytogenetics, molecular genetics, and disease biology of myelofibrosis (MF), including the approval of first- and second-generation JAK inhibitors and newer evidence on using JAK inhibitors in conjunction with hematopoietic stem cell transplantation
Category
Format
  • Online (archived)
Credits
  • AMA PRA Category 1 Credit(s)™
  • Hours of Participation
22132 Overcoming the Challenges of Acute and Chronic GVHD: Learning Workshop on the Integration of Novel Therapies into Modern Management Protocols
Recent clinical developments have transformed the management of graft-versus-host disease (GVHD) and have the potential to increase access to transplants and improve post-HCT outcomes.
Category
Format
  • Online (archived)
Credits
  • AMA PRA Category 1 Credit(s)™
  • Hours of Participation

Pages